Already a DIA Member? Sign in. Not a member? Join.

Iniciar sesión

¿Ha olvidado su ID de usuario? or ¿Ha olvidado su contraseña?

Not a Member?

Create Account and Join

Tokyo Big Sight

11 nov 2018 9:30 a.m. - 13 nov 2018 5:40 p.m.

3-11-1 Ariake, Koto-ku, Tokyo, 135-0063 Japan

15th DIA Japan Annual Meeting 2018

Innovative technologies such as AI, big data/genomics, and cell/gene therapies are poised to transform healthcare product development across the globe – join us to discuss these topics.

[V2-S5] Efforts to Raise Drug Literacy - How Should We Take Care It in Citizens Themselves Learn about Drugs - (Part1)

Session Chair(s)

Tomiko  Tawaragi

Tomiko Tawaragi

Director

RAD-AR Council, Japan

Junichi  Nishino, MSc, RPh

Junichi Nishino, MSc, RPh

Head, Regulatory Affairs Department

Otsuka Pharmaceutical Co., Ltd., Japan

“The citizen must strive to deepen knowledge and understanding on the effectiveness and safety of these products as well as properly using medicines and the like” in the Pharmaceuticals and Medical Devices Law. Because of the spread of the Internet, information is flooded, but is it all reliable information? Is it possible to say that the information from the patient’s point of view is now enough prepared? The information that the patient sought is diverse and it is recommended to consult a doctor / pharmacist first, but in addition to that, highly reliable information that the patient themselves can obtain is also necessary. In this session, we will organize the current status of pharmaceutical information in Japan and introduce efforts and issues relating to providing information to patients from speakers with different positions In Part 2 of V2 - S6, experts from industry, government and academia will discuss the future directions of drug information provision in Japan on each side of those who prepare and provide drug information, patients, people who explain to patients, and PMDA.

Speaker(s)

Junichi  Nishino, MSc, RPh

Current Situation and Issues for Providing Drug Information to Patients in Industries

Junichi Nishino, MSc, RPh

Otsuka Pharmaceutical Co., Ltd., Japan

Head, Regulatory Affairs Department

Ikuko  Yamaguchi

What Kind of Drug Information Are Needed by Patients? - Current Issues & Future Perspective from Patients Point of View -

Ikuko Yamaguchi

NPO COML, Japan

Board Chairperson

Susumu  Wakabayashi

What Kind of Drug Information Are Needed by Patients? - Current Issues & Future Perspective from Pharmacist Point of View -

Susumu Wakabayashi

Kyorin University Hospital, Japan

Department of Pharmacy

Kiyomi  Ueno, PhD

Current Situation and Issues for Providing Drug Information from PMDA to Patients

Kiyomi Ueno, PhD

Pharmaceuticals and Medical Devices Agency (PMDA), Japan

Director, Office of Safety I

¿Tiene una cuenta?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.